Headlines about celebrity weight-loss, trending hashtags on social media, publications in medical journals, health plans and employers concerned about rising drug costs – it feels like GLP-1 drugs are everywhere. Though the widespread attention is recent, these drugs are not new. The first drugs were originally approved in the early 2000s for use by people with diabetes. Their effectiveness at lowering blood sugar coupled with a low side effect profile and impact on weight loss has led to many developments in the area. And it is their impact on weight loss that has driven the extensive use. It is no surprise given the prevalence of obesity. Some experts predict that by 2030 almost half of adults in the U.S. will have obesity and in 29 states the number of adults with obesity will be over 50%.1 On its own, obesity adds almost $173 billion to the annual cost of health care in the U.S.2 And when we zoom in to the impact to individuals – obesity has a significant impact on physical, emotional and spiritual well-being.3
Weight: just one measure of health
Dr. Lia Gass Rodriguez, Chief Medical Officer
August 29, 2023